Low circulating levels of neuregulin 4 as a potential biomarker associated with the severity and prognosis of obesity-related metabolic diseases: a systematic review

Khanyisani Ziqubu,Phiwayinkosi V. Dludla,Sinenhlanhla X.H. Mthembu,Bongani Nkambule,Sithandiwe E. Mazibuko-Mbeje
DOI: https://doi.org/10.1080/21623945.2024.2390833
2024-08-23
Adipocyte
Abstract:Background Neuregulin 4 (Nrg4) is a brown adipose tissue-derived adipokine that greatly affects systemic metabolism and improves metabolic derangements. Although abnormal circulating levels of Nrg4 are common in obesity, it remains elusive whether low or elevated levels of this batokine are associated with the onset of metabolic diseases.
endocrinology & metabolism
What problem does this paper attempt to address?